Literature DB >> 6885110

Purification and characterization of a new cationic protein--eosinophil protein-X (EPX)--from granules of human eosinophils.

C G Peterson, P Venge.   

Abstract

The isolation and characterization of a new eosinophil-derived protein, eosinophil protein X (EPX) is here described. The purified EPX is a highly basic glycoprotein and shows one band on sodium dodecyl sulphate polyacrylamide gel electrophoresis and on agarose electrophoresis. The molecular weight of the unreduced protein was 23,000 and after reduction 19,000. EPX did not precipitate antibodies prepared to other eosinophil-derived proteins such as eosinophil cationic protein (ECP) or major basic proteins (MBP) or antibodies prepared to a number of neutrophil-derived proteins. The eosinophil origin of EPX was indicated by the linear correlation between the amount of EPX and the percentage of eosinophils in mixed leucocyte extracts prepared from normal individuals. The EPX content was estimated to be on average 10 micrograms/10(6) normal eosinophils. EPX from normal eosinophils and from eosinophils from one patient with hypereosinophilia seemed to be identical.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885110      PMCID: PMC1454232     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Procedures for the chromatographic determination of amino acids on four per cent cross-linked sulfonated polystyrene resins.

Authors:  S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

3.  Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils.

Authors:  G J Gleich; D A Loegering; K G Mann; J E Maldonado
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

4.  The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases.

Authors:  K Ohlsson; I Olsson
Journal:  Eur J Biochem       Date:  1973-07-16

5.  Radioimmunoassays employing immunosorbents.

Authors:  L Wide
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1969

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases.

Authors:  K Ohlsson; I Olsson
Journal:  Eur J Biochem       Date:  1974-03-01

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  Radioimmunoassay of human eosinophil cationic protein.

Authors:  P Venge; L E Roxin; I Olsson
Journal:  Br J Haematol       Date:  1977-11       Impact factor: 6.998

10.  The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X.

Authors:  K Fredens; R Dahl; P Venge
Journal:  J Allergy Clin Immunol       Date:  1982-11       Impact factor: 10.793

View more
  16 in total

Review 1.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

Review 2.  What is the role of the eosinophil?

Authors:  P Venge
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

3.  Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls.

Authors:  S C Bischoff; J Grabowsky; M P Manns
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

4.  An extragranular compartment of blood eosinophils contains eosinophil protein X/eosinophil-derived neurotoxin (EPX/EDN).

Authors:  Malgorzata Karawajczyk; Christer G B Peterson; Per Venge; Rodolfo C Garcia
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

5.  Interaction and complex-formation between the eosinophil cationic protein and alpha 2-macroglobulin.

Authors:  C G Peterson; P Venge
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

Review 6.  Eosinophils in eosinophilic endomyocardial disease.

Authors:  C J Spry
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

7.  Oxytocin-producing and vasopressin-producing eosinophils in the mouse spleen: immunohistochemical, immuno-electron-microscopic and in situ hybridization studies.

Authors:  K Kumamoto; T Matsuura; T Amagai; M Kawata
Journal:  Cell Tissue Res       Date:  1995-07       Impact factor: 5.249

Review 8.  Changing roles of eosinophils in health and disease.

Authors:  Glenn T Furuta; F Dan Atkins; Nancy A Lee; James J Lee
Journal:  Ann Allergy Asthma Immunol       Date:  2014-05-01       Impact factor: 6.347

Review 9.  Eosinophil-derived neurotoxin / RNase 2: connecting the past, the present and the future.

Authors:  H F Rosenberg
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

Review 10.  Cellular and immunological markers of allergic and intrinsic bronchial asthma.

Authors:  J C Virchow; C Kroegel; C Walker; H Matthys
Journal:  Lung       Date:  1994       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.